USANA Health Sciences, Inc.
USNA
$27.27
-$0.28-1.02%
NYSE
| 06/28/2025 | 03/29/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.49% | 16.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.49% | 16.82% | |||
| Cost of Revenue | -4.31% | 36.03% | |||
| Gross Profit | -5.80% | 12.59% | |||
| SG&A Expenses | -6.88% | 8.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.30% | 13.86% | |||
| Operating Income | 6.68% | 90.88% | |||
| Income Before Tax | 12.41% | 60.50% | |||
| Income Tax Expenses | 12.40% | 25.30% | |||
| Earnings from Continuing Operations | 12.42% | 107.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -804.46% | 473.33% | |||
| Net Income | 2.69% | 111.09% | |||
| EBIT | 6.68% | 90.88% | |||
| EBITDA | 1.88% | 96.66% | |||
| EPS Basic | 5.65% | 111.75% | |||
| Normalized Basic EPS | 6.76% | 63.46% | |||
| EPS Diluted | 6.12% | 114.25% | |||
| Normalized Diluted EPS | 6.84% | 63.13% | |||
| Average Basic Shares Outstanding | -2.81% | -0.29% | |||
| Average Diluted Shares Outstanding | -2.88% | -0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||